Results
1 -
1 of
1
(Click
here to explore results)
- Combination of biotransformation by P450 BM3 mutants with on-line post-column bioaffinity and mass spectrometric profiling as a novel strategy to diversify and characterize p38α kinase inhibitors. Vanina Rea, David Falck, Jeroen Kool, Frans J. J. de Kanter, Jan N. M. Commandeur, Nico P. E. Vermeulen, Wilfried M. A. Niessen, Maarten Honing
, Med. Chem. Commun.
, 2013
, 4
, 371